Akira Myoui
Overview
Explore the profile of Akira Myoui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
2203
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morimoto S, Tanaka Y, Nakata J, Fujiki F, Hasegawa K, Nakajima H, et al.
Cancer Immunol Immunother
. 2024 Nov;
74(1):15.
PMID: 39509060
Wilms' tumor protein 1 (WT1)-targeted immunotherapy has been used in patients with leukemia and solid tumors. However, the spontaneous WT1-specific immune response before WT1 peptide vaccination in patients with WT1-expressing...
2.
Ukon Y, Hosoya S, Morita K, Yokozeki Y, Kataoka T, Kitahara T, et al.
Stem Cell Reports
. 2024 May;
19(5):597-603.
PMID: 38701779
In Japan, the Act on Safety of Regenerative Medicine regulates unapproved regenerative medicine. Other nations market regenerative medicine products, bypassing regulatory approval. To identify unapproved orthopedic regenerative medicine, we have...
3.
Sasai M, Okamoto M, Tanigawa S, Okada S, Sugiyama D, Myoui A
Regen Ther
. 2024 Jan;
25:85-91.
PMID: 38187516
Introduction: The Act on the Safety of Regenerative Medicine enforced in Japan in 2014, regulates the manufacture of cellular processed products. However, with regards to the manufacturing facilities at medical...
4.
Ouedraogo A, Bougouma E, Palacpac N, Houard S, Nebie I, Sawadogo J, et al.
Front Immunol
. 2023 Nov;
14:1267372.
PMID: 37908361
Background: BK-SE36/CpG is a recombinant blood-stage malaria vaccine candidate based on the N-terminal serine repeat antigen5 (SE36), adsorbed to aluminium hydroxide gel and reconstituted, prior to administration, with synthetic oligodeoxynucleotides...
5.
Watari A, Fujiwara K, Yagi K, Tachibana K, Katsurada T, Myoui A, et al.
Biochem Biophys Res Commun
. 2022 Jun;
616:140-144.
PMID: 35679696
Although modulation of claudin-1-based tight junction (TJ) in stratum granulosum is an option for transdermal absorption of drugs, granular permeation enhancers have never been developed. We previously found that homoharringtonine...
6.
Kiyohara E, Tanemura A, Sakura K, Nakajima T, Myoui A, Yamazaki N, et al.
Cancer Immunol Immunother
. 2022 Jan;
71(8):2041-2049.
PMID: 34984539
Despite recent advance in immunotherapy agents, safe new therapies that enhance the effects of immune checkpoint inhibitors are still required to develop. We previously demonstrated that hemagglutinating virus of Japan-envelope...
7.
Outani H, Hamada K, Yasuda N, Ueda T, Myoui A, Yoshikawa H, et al.
J Orthop Sci
. 2021 May;
27(4):892-898.
PMID: 34024721
Background: The role of local surgery in patients with metastatic soft tissue sarcoma (STS) remains unknown. The study aims to assess the clinical outcomes and impact of surgical resection on...
8.
Ezoe S, Palacpac N, Tetsutani K, Yamamoto K, Okada K, Taira M, et al.
Vaccine
. 2020 Oct;
38(46):7246-7257.
PMID: 33012605
Background: BK-SE36 is blood-stage malaria vaccine candidate that is undergoing clinical trials. Here, the safety and immunogenicity of BK-SE36 with a novel adjuvant, CpG-ODN(K3) (thus, BK-SE36/CpG) was assessed in a...
9.
Takenaka S, Araki N, Ueda T, Kakunaga S, Imura Y, Hamada K, et al.
Sarcoma
. 2020 Apr;
2020:9672093.
PMID: 32317858
Methods: We retrospectively reviewed 33 patients who underwent osteoarticular ECIA after bone tumor resection from 1988 to 2014. We investigated complications, radiographic changes by the International Society of Limb Salvage...
10.
Kiyohara E, Tanemura A, Nishioka M, Yamada M, Tanaka A, Yokomi A, et al.
Cancer Immunol Immunother
. 2020 Feb;
69(6):1131-1140.
PMID: 32047956
Hemagglutinating virus of Japan (HVJ; Sendai virus) is an RNA virus that has cell fusion activity. HVJ-envelope (HVJ-E) is a UV-irradiated HVJ particle that loses viral replication and protein synthesis...